Metformin is a drug used to treat type 2 diabetes mellitus. While some may notice fallout or thinning when taking this medication, the connection might not be what you think. So, does metformin cause ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not have a complete picture of how it works. Scientists at Baylor College of ...

Whenever you start taking a new medication to treat a certain symptom or condition, it’s natural to wonder if the medicine is really making a difference for your health. When it comes to people who ...

Metformin is a drug used to treat type 2 diabetes mellitus. While some may notice fallout or thinning when taking this medication, the connection might not be what you think. So, does metformin cause ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Whenever you start taking a new medication to treat a certain symptom or condition, it’s natural to ...

The research on metformin and human longevity is scant, but that hasn’t stopped some people from experimenting with it. By Mohana Ravindranath A few years ago, Marc Provissiero, a movie producer ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable semaglutide, the active ingredient in weight loss juggernauts Wegovy and ...

MADRID — Metformin is taken every day by more than 200 million people worldwide. Its value as a glucose-lowering agent has been established for decades. But does metformin hold similar promise for ...

HealthDay News — Adding metformin to insulin therapy won’t boost glycemic control for overweight teens with type 1 diabetes, according to a study published in the Dec. 1 issue of JAMA. The new study, ...

The type 2 diabetes medication Ozempic has been hugely popular when prescribed off-label for weight loss, thanks to its ability to regulate your blood sugar and curb your appetite. But between ...

Adding metformin to standard of care (SOC) was significantly associated with a lower mortality risk compared with SOC alone among patients with high-volume metastatic hormone-sensitive prostate cancer ...